These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 15170913)
1. Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor. Santos LL; Lacey D; Yang Y; Leech M; Morand EF J Rheumatol; 2004 Jun; 31(6):1038-43. PubMed ID: 15170913 [TBL] [Abstract][Full Text] [Related]
2. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Lacey D; Sampey A; Mitchell R; Bucala R; Santos L; Leech M; Morand E Arthritis Rheum; 2003 Jan; 48(1):103-9. PubMed ID: 12528110 [TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta. Onodera S; Nishihira J; Koyama Y; Majima T; Aoki Y; Ichiyama H; Ishibashi T; Minami A Arthritis Rheum; 2004 May; 50(5):1437-47. PubMed ID: 15146413 [TBL] [Abstract][Full Text] [Related]
4. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids. Toh ML; Yang Y; Leech M; Santos L; Morand EF Arthritis Rheum; 2004 Oct; 50(10):3118-28. PubMed ID: 15476200 [TBL] [Abstract][Full Text] [Related]
5. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis. Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214 [TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Leech M; Metz C; Hall P; Hutchinson P; Gianis K; Smith M; Weedon H; Holdsworth SR; Bucala R; Morand EF Arthritis Rheum; 1999 Aug; 42(8):1601-8. PubMed ID: 10446857 [TBL] [Abstract][Full Text] [Related]
7. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Sampey AV; Hall PH; Mitchell RA; Metz CN; Morand EF Arthritis Rheum; 2001 Jun; 44(6):1273-80. PubMed ID: 11407686 [TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts. Bradley K; Scatizzi JC; Fiore S; Shamiyeh E; Koch AE; Firestein GS; Gorges LL; Kuntsman K; Pope RM; Moore TL; Han J; Perlman H Arthritis Rheum; 2004 Jan; 50(1):78-87. PubMed ID: 14730602 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Chun KS; Kim SH; Song YS; Surh YJ Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583 [TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of cyclooxygenase 2-generated prostaglandin E2 synthesis in rheumatoid arthritis synoviocytes by taurine chloramine. Kontny E; Rudnicka W; Kowalczewski J; Marcinkiewicz J; Maslinski W Arthritis Rheum; 2003 Jun; 48(6):1551-5. PubMed ID: 12794822 [TBL] [Abstract][Full Text] [Related]
11. MAP kinase subtypes and Akt regulate diosgenin-induced apoptosis of rheumatoid synovial cells in association with COX-2 expression and prostanoid production. Liagre B; Leger DY; Vergne-Salle P; Beneytout JL Int J Mol Med; 2007 Jan; 19(1):113-22. PubMed ID: 17143555 [TBL] [Abstract][Full Text] [Related]
12. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Schett G; Tohidast-Akrad M; Smolen JS; Schmid BJ; Steiner CW; Bitzan P; Zenz P; Redlich K; Xu Q; Steiner G Arthritis Rheum; 2000 Nov; 43(11):2501-12. PubMed ID: 11083274 [TBL] [Abstract][Full Text] [Related]
13. Increase of cyclooxygenase-2 expression by interleukin 15 in rheumatoid synoviocytes. Min SY; Hwang SY; Jung YO; Jeong J; Park SH; Cho CS; Kim HY; Kim WU J Rheumatol; 2004 May; 31(5):875-83. PubMed ID: 15124245 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase 2-derived prostaglandin E2 production by corticotropin-releasing hormone contributes to the activated cAMP response element binding protein content in rheumatoid arthritis synovial tissue. McEvoy AN; Bresnihan B; FitzGerald O; Murphy EP Arthritis Rheum; 2004 Apr; 50(4):1132-45. PubMed ID: 15077295 [TBL] [Abstract][Full Text] [Related]
15. Role of protein tyrosine kinase in IL-1 beta induced activation of mitogen-activated protein kinase in fibroblast-like synoviocytes of rheumatoid arthritis. Lu H; Sun T; Yao L; Zhang Y Chin Med J (Engl); 2000 Oct; 113(10):872-6. PubMed ID: 11775830 [TBL] [Abstract][Full Text] [Related]
16. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Niiro H; Otsuka T; Ogami E; Yamaoka K; Nagano S; Akahoshi M; Nakashima H; Arinobu Y; Izuhara K; Niho Y Biochem Biophys Res Commun; 1998 Sep; 250(2):200-5. PubMed ID: 9753607 [TBL] [Abstract][Full Text] [Related]